GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
2.390
-0.175 (-6.82%)
Mar 9, 2026, 4:00 PM EDT - Market closed
GRI Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.16 | 4.47 | 8.16 | 2 | 0.81 | |
| Research & Development | 6.82 | 3.77 | 3.23 | 0.24 | 0.25 | |
| Other Operating Expenses | - | - | -0.25 | - | - | |
| Operating Expenses | 11.98 | 8.24 | 11.14 | 2.24 | 1.06 | |
| Operating Income | -11.98 | -8.24 | -11.14 | -2.24 | -1.06 | |
| Interest Expense | - | - | -2.08 | -0.65 | -0.55 | |
| Interest & Investment Income | 0.02 | 0.03 | - | - | - | |
| Other Non Operating Income (Expenses) | - | 0 | 0.18 | - | - | |
| EBT Excluding Unusual Items | -11.96 | -8.21 | -13.04 | -2.89 | -1.61 | |
| Other Unusual Items | - | - | - | -0.33 | 0.05 | |
| Pretax Income | -11.96 | -8.21 | -13.04 | -3.22 | -1.56 | |
| Net Income | -11.96 | -8.21 | -13.04 | -3.22 | -1.56 | |
| Preferred Dividends & Other Adjustments | - | 1.91 | - | - | - | |
| Net Income to Common | -11.96 | -10.12 | -13.04 | -3.22 | -1.56 | |
| Shares Outstanding (Basic) | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 0 | - | - | - | - | |
| EPS (Basic) | -121.80 | - | - | - | - | |
| EPS (Diluted) | -121.80 | - | - | - | - | |
| Free Cash Flow | -10.19 | -8.61 | -9 | -1.09 | -0.85 | |
| Free Cash Flow Per Share | -103.80 | - | - | - | - | |
| EBITDA | -11.97 | -8.23 | -11.13 | -2.24 | -1.06 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -11.98 | -8.24 | -11.14 | -2.24 | -1.06 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.